Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Medina, C. O’Neill, M. Sweeney, Jasenka Guduric‐Fuchs, T. Gardiner, D. Simpson, Alan Stitt (2010)
Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identitiesBMC Medical Genomics, 3
T. Asahara, T. Murohara, A. Sullivan, Marcy Silver, R. Zee, Tong Li, B. Witzenbichler, G. Schatteman, J. Isner (1997)
Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 275
Xiaocong Li, Chun-yuan Chen, Liming Wei, Qing Li, X. Niu, Yanjun Xu, Yang Wang, Jungong Zhao (2016)
Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function.Cytotherapy, 18 2
F. Proulx, E. Seidman, D. Karpman (2001)
Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic SyndromePediatric Research, 50
D. Patschan, Krystina Krupincza, S. Patschan, Zhong Zhang, C. Hamby, M. Goligorsky (2006)
Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning.American journal of physiology. Renal physiology, 291 1
Zengbin Wu, Yang Yu, L. Niu, A. Fei, Shuming Pan (2016)
IGF-1 protects tubular epithelial cells during injury via activation of ERK/MAPK signaling pathwayScientific Reports, 6
N. Rafat, B. Tönshoff, A. Bierhaus, G. Beck (2013)
Endothelial progenitor cells in regeneration after acute lung injury: do they play a role?American journal of respiratory cell and molecular biology, 48 4
C. Urbich, A. Aicher, C. Heeschen, Elisabeth Dernbach, W. Hofmann, A. Zeiher, S. Dimmeler (2005)
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.Journal of molecular and cellular cardiology, 39 5
A. Friedrich, M. Bielaszewska, Wen-lan Zhang, M. Pulz, T. Kuczius, A. Ammon, H. Karch (2002)
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.The Journal of infectious diseases, 185 1
J. Melero-Martin, Z. Khan, Arnaud Picard, Xiao Wu, S. Paruchuri, J. Bischoff (2007)
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.Blood, 109 11
M. Amaral, F. Sacerdoti, C. Jancic, H. Repetto, A. Paton, J. Paton, C. Ibarra (2013)
Action of Shiga Toxin Type-2 and Subtilase Cytotoxin on Human Microvascular Endothelial CellsPLoS ONE, 8
M. Richardson, M. Yoder (2011)
Endothelial progenitor cells: quo vadis?Journal of molecular and cellular cardiology, 50 2
Xiaocong Li, Chunyu Jiang, Jungong Zhao (2016)
Human endothelial progenitor cells-derived exosomes accelerate cutaneous wound healing in diabetic rats by promoting endothelial function.Journal of diabetes and its complications, 30 6
S. Santo, A. Fuchs, R. Periasamy, S. Seiler, H. Widmer (2016)
The Cytoprotective Effects of Human Endothelial Progenitor Cell-Conditioned Medium against an Ischemic Insult Are Not Dependent on VEGF and IL-8Cell Transplantation, 25
N. Rafat, Christine Dacho, Gregor Kowanetz, Christian Betzen, B. Tönshoff, B. Yard, G. Beck (2014)
Bone marrow-derived progenitor cells attenuate inflammation in lipopolysaccharide-induced acute respiratory distress syndromeBMC Research Notes, 7
P. Ray, D. Acheson, R. Chitrakar, A. Cnaan, Kathleen Gibbs, G. Hirschman, Erica Christen, H. Trachtman (2002)
Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome.Journal of the American Society of Nephrology : JASN, 13 3
N Rafat, G Kowanetz, J Krebs, C Tsagogiorgas, C Betzen, V Ghezel-Ahmadi, B Yard, G Beck, C Dacho (2014)
Therapeutic effects of bone marrow-derived progenitor cells in lipopolysaccharide-induced acute respiratory distress syndrome, 4
M. Bielaszewska, H. Karch (2005)
Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endotheliumThrombosis and Haemostasis, 94
MA Karmali (2004)
Infection by Shiga toxin-producing Escherichia coli: an overview, 26
P. Tarr, Carrie Gordon, W. Chandler (2005)
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndromeThe Lancet, 365
S. Suga, S. Suga, Yoon-Goo Kim, Yoon-Goo Kim, A. Joly, A. Joly, E. Puchacz, E. Puchacz, D. Kang, D. Kang, J. Jefferson, J. Jefferson, J. Abraham, J. Abraham, J. Hughes, J. Hughes, Richard Johnson, Richard Johnson, G. Schreiner, G. Schreiner (2001)
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.Kidney international, 60 4
Lindsay Keir, R. Coward (2010)
Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathyPediatric Nephrology (Berlin, Germany), 26
D. Sukmawati, R. Tanaka (2015)
Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine.American journal of translational research, 7 3
C. Patry, S. Orfanos, N. Rafat (2015)
Translational research in ARDS patients: new biological phenotypesIntensive Care Medicine, 41
S. Balaji, A. King, T. Crombleholme, S. Keswani (2013)
The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing.Advances in wound care, 2 6
Andreas Bauwens, M. Bielaszewska, B. Kemper, P. Langehanenberg, G. Bally, R. Reichelt, D. Mulac, H. Humpf, A. Friedrich, K. Kim, H. Karch, J. Müthing (2010)
Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cellsThrombosis and Haemostasis, 105
C. Urbich, S. Dimmeler (2004)
Endothelial Progenitor Cells: Characterization and Role in Vascular BiologyCirculation Research, 95
S Di Santo, A-L Fuchs, R Periasami, S Seiler, HR Widmer (2016)
The cytoprotective effects of human endothelial progenitor cells conditioned medium against an ischemic insult are VEGF and IL-8 dispensable, 25
Chao-Hung Wang, Po‐Hsun Huang, Jaw-wen Chen, Shing-Jong Lin, Ming-Feng Lee, N. Yang, W. Cherng (2013)
Clinical Application of Endothelial Progenitor Cell: Are We Ready?Acta Cardiologica Sinica, 29 6
Christian Betzen, K. Plotnicki, Farnoosh Fathalizadeh, K. Pappan, T. Fleming, M. Bielaszewska, H. Karch, B. Tönshoff, N. Rafat (2016)
Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.The Journal of infectious diseases, 213 6
S. Ostroff, P. Tarr, M. Neill, J. Lewis, Nancy Hargrett-Bean, J. Kobayashi (1989)
Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections.The Journal of infectious diseases, 160 6
Beatriz Marcos‐Ramiro, Diego García-Weber, J. Millán (2014)
TNF-induced endothelial barrier disruption: beyond actin and RhoThrombosis and Haemostasis, 112
F. Scheutz, L. Teel, L. Beutin, D. Piérard, G. Buvens, H. Karch, A. Mellmann, A. Caprioli, R. Tozzoli, S. Morabito, N. Strockbine, A. Melton-Celsa, Maria Sanchez, S. Persson, A. O’Brien (2012)
Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx NomenclatureJournal of Clinical Microbiology, 50
C. Frank, D. Werber, J. Cramer, M. Askar, M. Faber, M. Heiden, H. Bernard, A. Fruth, R. Prager, A. Spode, M. Wadl, A. Zoufaly, S. Jordan, M. Kemper, P. Follin, L. Müller, L. King, B. Rosner, U. Buchholz, K. Stark, G. Krause (2011)
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.The New England journal of medicine, 365 19
J. Hur, C. Yoon, Hyo‐Soo Kim, Jin-Ho Choi, Hyun-Jae Kang, Kyung-Kook Hwang, B. Oh, M. Lee, Young‐Bae Park (2004)
Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to NeovasculogenesisArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 24
M. Hristov, A. Zernecke, E. Liehn, C. Weber (2007)
Regulation of endothelial progenitor cell homing after arterial injuryThrombosis and Haemostasis, 98
M. Karmali (2004)
Infection by shiga toxin-producing Escherichia coliMolecular Biotechnology, 26
H. Karch, P. Tarr, M. Bielaszewska (2005)
Enterohaemorrhagic Escherichia coli in human medicine.International journal of medical microbiology : IJMM, 295 6-7
J. Wils, J. Favre, J. Bellien (2017)
Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes.Pharmacology & therapeutics, 170
N. Rafat, C. Hanusch, P. Brinkkoetter, J. Schulte, J. Brade, J. Zijlstra, F. Woude, K. Ackern, B. Yard, G. Beck (2007)
Increased circulating endothelial progenitor cells in septic patients: Correlation with survivalCritical Care Medicine, 35
L. Bach (2014)
Endothelial cells and the IGF system.Journal of molecular endocrinology, 54 1
Jieyuan Zhang, Chun-yuan Chen, Bin Hu, X. Niu, Xiaolin Liu, Guowei Zhang, Changqing Zhang, Qing Li, Yang Wang (2016)
Exosomes Derived from Human Endothelial Progenitor Cells Accelerate Cutaneous Wound Healing by Promoting Angiogenesis Through Erk1/2 SignalingInternational Journal of Biological Sciences, 12
D. Sieveking, A. Buckle, D. Celermajer, Martin Ng (2008)
Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.Journal of the American College of Cardiology, 51 6
C. Sussman (2016)
Tgf-β, Notch, and HGF weave a tangled web of kidney repair.American journal of physiology. Renal physiology, 310 8
S. Horie, C. Masterson, J. Devaney, J. Laffey (2016)
Stem cell therapy for acute respiratory distress syndrome: a promising future?Current Opinion in Critical Care, 22
Endothelial injury with consecutive microangiopathy and endothelial dysfunction plays a central role in the pathogenesis of the postenteropathic hemolytic uremic syndrome (D + HUS). To identify new treatment strategies, we examined the regenerative potential of endothelial progenitor cells (EPCs) in an in vitro model of Shiga toxin (Stx) 2a-induced glomerular endothelial injury present in D + HUS and the mechanisms of EPC-triggered endothelial regeneration. We simulated the proinflammatory milieu present in D + HUS by priming human renal glomerular endothelial cells (HRGECs) with tumor necrosis factor-α before stimulation with Stx2a. This measure led to a time- and concentration-dependent decrease of HRGEC viability of human renal glomerular endothelial cells as detected by a colorimetric assay. Coincubation with EPCs (104–105 cells/ml) under dynamic flow conditions led to a significant improvement of cell viability in comparison to untreated monolayers (0.45 ± 0.06 vs. 0.16 ± 0.04, P = 0.003). A comparable regenerative effect of EPCs was observed in a coculture model using cell culture inserts (0.41 ± 0.05 vs. 0.16 ± 0.04, P = 0.003) associated with increased concentrations of vascular endothelial growth factor, insulin-like growth factor I, fibroblast growth factor-2, and hepatocyte growth factor in the supernatant. Treatment of Stx2a-injured monolayers with a combination of these growth factors imitated this effect. EPCs did not show distinct sings of migration and angiogenic tube formation in functional assays. These data demonstrate that EPCs significantly improve endothelial viability after Stx2a-induced injury in vitro and that this effect is associated with the release of growth factors by EPCs.
American Journal of Physiology-Renal Physiology – The American Physiological Society
Published: Oct 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.